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Abstract 
Particulate matter (PM) exposure during in utero life may entail adverse health outcomes in 
later-life. Air pollution’s adverse effects are known to alter gene expression profiles, which 
can be regulated by microRNAs (miRNAs). We investigate the potential influence of air 
pollution exposure in prenatal life on placental miRNA expression. Within the framework of 
the ENVIRONAGE birth cohort, we measured the expression of six candidate miRNAs in 
placental tissue from 210 mother-newborn pairs by qRT-PCR. Trimester-specific PM2.5 
exposure levels were estimated for each mother's home address using a spatiotemporal 
model. Multiple regression models were used to study miRNA expression and in utero 
exposure to PM2.5 over various time windows during pregnancy. The placental expression of 
miR-21 (-33.7%, 95% CI: -53.2 to -6.2, P=0.022), miR-146a (-30.9%, 95% CI: -48.0 to -8.1, 
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P=0.012) and miR-222 (-25.4%, 95% CI: -43.0 to -2.4, P=0.034) was inversely associated 
with PM2.5 exposure during the 2
nd
 trimester of pregnancy, while placental expression of 
miR-20a and miR-21 was positively associated with 1
st
 trimester exposure. Tumor suppressor 
phosphatase and tensin homolog (PTEN) was identified as a common target of the miRNAs 
significantly associated with PM exposure. Placental PTEN expression was strongly and 
positively associated (+59.6% per 5 µg/m³ increment, 95% CI: 26.9 to 100.7, P<0.0001) with 
3
rd
 trimester PM2.5 exposure. Further research is required to establish the role these early 
miRNA and mRNA expression changes might play in PM-induced health effects. We provide 
molecular evidence showing that in utero PM2.5 exposure affects miRNAs expression as well 
as its downstream target PTEN. 
Keywords 
miRNAs, placenta, air pollution, expression analysis, particulate matter 
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Abbreviations 
miRNA: microRNA; 
PM: Particulate matter; 
PM2.5: Particulate matter with diameter less than 2.5 μm; 
NO2: Nitrogen dioxide; 
CI: Confidence interval; 
BMI: Body mass index; 
FDR: False discovery rate; 
qRT-PCR: Quantitative real-time polymerase chain reaction; 
RS: Reporter assay; 
qP: qPCR; 
WB: Western blot; 
IP: Immunoprecipitation; 
MA: Microarrays; 
Pr: Proteomics; 
NGS: Next generation sequencing; 
IQR: Interquartile range; 
CCND1: Cyclin D1; 
CDKN1A/B: Cyclin-dependent kinase inhibitor 1A/B; 
TGF/TGFBR2: Transforming growth factor / Transforming growth factor beta receptor 
II; 
STAT3/5: Signal transducer and activator of transcription 3/5; 
E2F1: E2F transcription factor 1; 
KIT: v-kit hardy-zuckerman 4 feline sarcoma viral oncogene homolog; 
HIF1A: Hypoxia inducible factor 1, alpha subunit; 
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PTEN: Phosphatase and tensin homolog;  
APAF1: Apoptotic peptidase activating factor 1; 
CDC25A: Cell Division cycle 25A; 
BCL2: B-cell CLL/lymphoma 2; 
TLR: Toll-like receptor; 
TRAF6: Tumor necrosis factor (TNF) receptor-associated factor 6; 
NF-kB/ NFKB1: Nuclear factor of kappa light polypeptide gene enhancer in B-cells/1; 
IRAK1: Interleukin-1 receptor-associated kinase 1; 
ETS1: V-Ets avian erythroblastosis virus E26 oncogene homolog 1; 
FOS: FBJ Murine osteosarcoma viral oncogene homolog; 
MMP1: Matrix metallopeptidase 1; 
FOXO3: Forkhead box O3; 
PI3K/AKT: Phosphatidylinositol-3-kinase/Protein kinase B; 
VEGF: Vascular endothelial growth factor; 
GAPDH: Glyceraldehyde-3-phosphate dehydrogenase, 
IPO8: Importine 8, 
POLR2A: Polymerase (RNA) II (DNA Directed) Polypeptide A; 
UBC: Ubiquitin C; 
TERT: Telomerase reverse transcriptase; 
TERC: Telomerase RNA template; 
Hg: Mercury; 
Pb: Lead 
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Introduction 
Particulate matter (PM) is an airborne mixture of solid particles and liquid droplets,
1
 
of which fine particles with a diameter less than 2.5 µm (PM2.5) can be inhaled deeply into 
the lungs. This leads to the generation of oxidative stress and the induction of inflammation.
2, 
3
 PM2.5 exposure contributes to the initiation and progression of various diseases affecting the 
respiratory and cardiovascular system.
4-7
 According to Barker’s hypothesis, early life 
perturbations are crucial for the development of disease later in life.
8, 9
 Exposure to ambient 
PM2.5 pollution during pregnancy is significantly associated with increased risk of low birth 
weight at term in mother-child cohorts of 12 European countries
10
 and preterm birth in a very 
large cohort of singleton pregnancies (≥20 weeks of gestation) from three states of the 
USA.
11
 
Prenatal PM exposure has been shown to affect placental weight,
12
 function and 
morphology,
12, 13
 and gene expression.
14, 15
 These processes affect fetal programming and 
could thereby increase the risk of disease later in life.
16
 
MicroRNAs (miRNAs) are single-stranded small non-coding RNAs of approximately 
22 nucleotides that play a key role in the regulation of gene expression at the 
posttranscriptional level in many cellular processes, including proliferation and apoptosis, 
which could lead to diseases such as cancer.
17-21
 Notably, miRNAs are able to regulate up to 
30% of the human genome,
22
 where one single miRNA can affect the expression of hundreds 
of genes, whereas one gene can be targeted by many miRNAs.
23
 
In healthy adults, the blood-leukocyte expression of miR-146a and miR-222 was 
found inversely associated with air pollution exposure,
24
 while miR-21 and miR-222 
expression was significantly increased in steel plant workers after exposure to metal-rich 
PM.
25
 Inhalation of ozone was shown to disrupt miRNA expression profiles in human 
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induced-sputum samples and network analysis of the 10 miRNAs with significantly increased 
expression levels revealed an association with diverse biological processes, including 
inflammatory and immune response signaling.
26
 
Interestingly, exposure to environmental agents induces altered miRNA expression 
patterns both in placental cell lines
27
 and cord blood,
28
 which could potentially contribute to 
adverse fetal development and health outcomes later in life. Maccani et al.
29
 showed that 
maternal smoking during pregnancy was inversely associated with placental expression of 
miR-16, miR-21 and miR-146a. Therefore, placenta could be used as an appropriate target 
organ to assess the impact of air pollution on miRNA expression in the early-life 
environment. 
To date, the potential modulation of placental miRNA expression in association with 
prenatal exposure to air pollution has not been investigated. For this purpose, six candidate 
miRNAs, namely miR-16, -20a, -21, -34a, -146a and -222, related to important cellular 
processes
30
 were selected, based on a systematic review.
31
 miR-16 and miR-21 are involved 
in cell cycle, proliferation, and apoptosis.
29, 32-37
 miR-146a has been described as a regulator 
of inflammation.
29, 38
 miR-20a, miR-34a, and miR-222 function in angiogenesis.
39-42
 Maternal 
exposure to air pollution has been suggested to adversely affect pregnancy by inducing 
oxidative stress and inflammation,
5
 which may result in impaired placental angiogenesis.
12
 
In the current study, we investigate whether in utero exposure to particulate matter 
and nitrogen dioxide during different periods of gestation is associated with placental 
expression of six candidate miRNAs. We hypothesize that in utero PM exposure might 
induce epigenetic alterations at the placental miRNA level. To assess whether any miRNA 
expression alterations could have a functional effect, we also measured expression of a 
downstream mRNA target. 
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Results 
Characteristics of the study population and air pollution exposure 
In the present study, 210 mother-newborns pairs with a mean age of 29.5 years (±4.3) 
and mean pre-gestational BMI of 24.1 kg/m
2
 (±4.8) were included. As shown in Table 1, 
70% of women never smoked, 14.8% smoked during pregnancy (current-smokers), and the 
remaining 15.2% quit smoking at the start of pregnancy (past-smokers). For approximately 
half of the mothers, the newborn was their first child, and 56.2% of the mothers were highly 
educated. One hundred and fifteen (54.8%) newborns were girls, had a mean gestational age 
of 39.2 weeks (±1.3), and an average birth weight of 3,395 g (±427); 190 (90.5%) of the 
newborns had European-Caucasian ethnicity. The frequencies of conception of pregnancies 
were approximately equally distributed into the four seasons, with the highest rate (29.1%) 
observed in summer. The average apparent temperature during the 3
rd
 trimester of pregnancy 
was divided into quartiles of the distribution. 
The mean outdoor exposures to PM2.5 and NO2 averaged for each of the three 
trimesters of pregnancy are presented in Table 2. 
Association of miRNAs with exposure to air pollution 
Figure 1 shows the change in placental miRNA expression in association with 
exposure across the three trimesters of pregnancy for PM2.5 and NO2. 
PM2.5 exposure during the 2
nd
 trimester of gestation was most significantly associated 
with miRNA expression changes. Placental miR-16 (-24.7%, 95% CI: -44.4 to 2.1, P=0.069), 
miR-20a (-26.0%, 95% CI: -45.2 to 0.0, P=0.052), miR-21 (-33.7%, 95% CI: -53.2 to -6.2, 
P=0.022), miR-146a (-30.9%, 95% CI: -48.0 to -8.1, P=0.012), and miR-222 (-25.4%, 95% 
CI: -43.0 to -2.4, P=0.034) expression were inversely associated with PM2.5 exposure during 
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the 2
nd
 trimester of pregnancy. Additionally, miR-146a expression was inversely associated (-
21.8%, 95% CI: -39.7 to 1.5, P=0.066) with 3
rd
 trimester exposure. We found positive 
associations between 1
st
 trimester particulate air pollution exposure and placental expression 
of miR-20a (+70.9%, 95% CI: 16.7 to 150.3, P=0.007) and miR-21 (+73.7%, 95% CI: 11.7 
to 170.1, P=0.015). All estimates were calculated for an increase in PM2.5 exposure of 5 
µg/m
3
. 
We obtained similar findings for NO2 exposure, miR-20a (-26.2%, 95% CI: -46.0 to 
0.9, P=0.058), miR-21 (-31.3%, 95% CI: -51.9 to -1.6, P=0.042), and miR-146a (-23.8%, 
95% CI: -43.3 to 2.3, P=0.072) were inversely associated with NO2 exposure during the 2
nd
 
trimester, while a positive association was observed for the placental expression of miR-21 
(+41.4%, 95% CI: -3.4 to 106.9, P=0.076) at term with NO2 exposure during the 1
st
 trimester 
of pregnancy. Estimates were calculated for an increase in NO2 exposure of 5 µg/m
3
. 
miRNA target prediction and pathway analysis 
A list with putative predicted targets compiled from mirTarBase and DIANA-TarBase 
with all relevant information about their function and methods used for target validation is 
provided in Table 3. 
Pathway analysis was performed in MetaCore™ by uploading top 15 experimentally 
validated miRNA targets of miR-20a, miR-21, miR-146a, and miR-222; the 5 most 
significant enriched pathways for each set of miRNA targets are indicated in Table 4. Within 
the top significant identified pathways we identified cell cycle- and cancer-related pathways 
from the putative targets of miR-20a, apoptosis- and cancer-related pathways for miR-21, 
immune-related pathways for miR-146a, and hematopoiesis-, cell cycle- and immune-related 
pathways for miR-222. 
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The common putative pathways regulated by the top predicted targets (n=15) of the 
significant associated miRNAs with PM exposure were identified using the pathway map tool 
in MetaCore™. The top 10 significant common pathways for all PM-related miRNAs are 
illustrated in Figure 2. Furthermore, a gene network was generated for the predicted miRNA 
targets (Figure 3). 
Validation of miRNA target 
PTEN is a predicted target for three of the four miRNAs significantly associated with 
PM exposure in placental tissue (Figure 3). In order to validate this miRNA target, we 
measured its gene expression (PTEN) by means of qRT-PCR in a subset (n=181) of our study 
population. As expected, the placental relative PTEN expression was inversely correlated 
with the three miRNA candidates: the Pearson correlation coefficients were -0.18 (P=0.013), 
-0.27 (P=0.0003), and -0.25 (P=0.0007), for miR-20a, miR-21, and miR-222, respectively. 
Placental relative PTEN expression was strongly and positively associated with third 
trimester PM2.5 exposure (+59.6% per 5 µg/m³ increment, 95% CI: 26.9 to 100.7, P<0.0001) 
and borderline significantly associated with third trimester NO2 exposure (+25.7% per 5 
µg/m³ increment, 95% CI: -0.9 to 59.4, P=0.061). The detailed estimates of the other 
trimesters for PTEN and the three regulatory miRNAs are given in Supplementary Figure 
S1. 
Discussion 
Epigenetic modifications by miRNAs may provide a plausible link between in utero 
exposure to particulate air pollution and alterations in gene expression that might lead to 
disease phenotypes related to fetal programming.
16
 The placenta plays a crucial role in 
transfer of nutrients and oxygen from the mother to the fetus. Therefore, perturbations in the 
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maternal environment can be transmitted to the fetus by changes in placental functions. Since 
particulate matter exposure has been shown to affect miRNA expression both in animal
43
 and 
human studies,
44
 it is perceivable that miRNAs could be involved in regulating the in utero 
response to PM exposure as well. Therefore, we studied the expression of six candidate 
miRNAs involved in many biological processes (cell proliferation, cell cycle, apoptosis, 
inflammation, angiogenesis) related to air pollution or environmental stressors exposure.
25, 29, 
31
 We found that the placental expression of several candidate miRNAs involved in important 
biological processes was inversely associated with in utero particulate air pollution exposure, 
mainly during the second trimester of pregnancy. These molecular epidemiological 
observations might have important health consequences as downregulation of miR-16 and 
miR-21 has been shown to be significantly associated with fetal growth restriction,
37
 a 
condition which may result in many complications including preeclampsia.
45
 
Our inverse association between second trimester PM exposure and placental miR-
miR-146a expression at birth is consistent with observations in a recent study
46
 in which 
miR-146a expression at birth, among other miRNAs, was found to be associated with 
placental Pb levels. Our observations on PM-induced placental miRNA changes in newborns 
are parallel to observations in placentas of mothers who smoked during pregnancy. 
Significant lower miRNAs expression of miR-16, miR-21, and miR-146a, were identified in 
placentas from smoking mothers.
29
 However, in our study population, smoking had no 
significant effect on studied miRNA expression (data not shown). 
Similarly, investigators of the Normative Aging Study showed in 77-year-old men 
downregulation of blood leukocyte miRNAs expression in miR-21, miR-146a, and miR-222 
in association with 7-day average PM and black carbon exposure.
24
 However, Bollati et al.
25
 
observed significantly higher expression of miR-21 and miR-222 pre- and post-exposure in 
peripheral blood leukocytes from 63 steel factory workers. The differences between the 
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direction of the effect in which PM exposure on the studied miRNAs between our 
observations in newborns and the Normative Ageing Study
24
 might be attributed to the 
different tissue, duration, magnitude, and/or composition of the PM exposure.  
Our study investigated the association between placental expression of miRNA at 
birth in associations with exposure to ambient particulate air pollution for different time 
windows of gestation. The sensitivity of the epigenetic system to environmental factors 
occurs primarily during the period of developmental plasticity, as this is the time point when 
epigenetic marks undergo critical modifications.
47
 Previously, we reported that exposure to 
particulate air pollution from fertilization up to and including embryo implantation was 
associated with lower global DNA methylation levels in placental tissue at birth.
48
 In the 
current study, we observed significant associations between lower miRNA expression and 
PM exposure during the second trimester of pregnancy, which indicates that this is a critical 
time window for PM-related epigenetic changes at the level of miRNA. For miR-20a and -21, 
we found significant higher placental expression at birth in association with prenatal 
particulate matter exposure during the 1
st
 trimester, in contrast to an inverse association with 
PM exposure during the second trimester. It is not uncommon that expression changes are 
specific to the time window of exposure; for example, miR-9 expression decreased upon 
ethanol exposure in early development stages in mice and fish,
49,50
 whereas it increased at 
later developmental stages in mice and in adult rats.
51, 52
 It is conceivable that a similar 
mechanism of action could regulate the response to air pollution exposure for the different 
trimesters of pregnancy, as each developmental time window has its own hallmark 
physiological events, regulated by different molecular processes.
53
 
Recently, miRNA expression has been also shown to be regulated by telomerase 
reverse transcriptase (TERT) at early stages of miRNA biogenesis. Particularly, suppression 
of TERT decreased the levels of miRNA expression in human cells, including miR-20a, miR-
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21, and miR-222.
54
 TERT and telomerase RNA component (TERC) are essential elements of 
telomerase, a ribonucleoprotein complex responsible for the telomere elongation.
55
 
Previously, higher maternal residential traffic exposure has been associated with shorter 
placental telomere length at birth,
56
 which may be linked to decreased telomerase activity. 
Hence, our observed placental miRNA alterations could be also mediated by decreased levels 
of telomerase activity caused by maternal PM exposure during pregnancy. 
To further understand the biological function of these miRNAs, we identified their 
putative targets and performed overrepresentation enrichment analysis on the experimentally 
validated targets of significantly associated miRNAs with PM exposure. Targets of miR-20a 
were found to potentially regulate pathways involved mainly in cell cycle [CCND1, 
CDKN1A(p21), TGFBR2, STAT3] and cancer [E2F1, KIT, CDKN1A(p21), HIF1A]. For miR-
21, its putative targets regulated pathways in cancer (PTEN, APAF1), cell cycle (E2F1, 
CDC25A), and apoptosis (APAF1, BCL2, E2F1). For miR-146a, immune-related pathways 
(TLR2, TRAF6, NFKB1, IRAK1, TLR4) were predominantly regulated. Lastly, for miR-222, 
pathways involved in immune responses (ETS1, FOS, MMP1, FOXO3A, STAT5) and 
hematopoiesis [FOXO3A, KIT, CDKN1B (p27), STAT5] were identified. In addition, cell 
cycle-related pathway was found to be the most significant among the shared regulated 
pathways by the putative targets of the significant miRNAs (miR-20a, -21, -146a, and -222) 
associated with air pollution. 
A common putative target of the miR-20a, miR-21, and miR-222 (Figure 3), PTEN, 
is involved in many key cellular processes by negatively regulating PI3K/AKT pathway 
involving cell survival, cell cycle, angiogenesis, and metabolism.
57
 Interestingly, in a 
validation experiment, we demonstrated that PTEN expression inversely correlated with miR-
20a, miR-21, and miR-222 expression in placental tissue. These findings confirm the 
miRNA-PTEN co-expression in placental tissue, which is an important criterion for the 
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validation of miRNA targets.
58
 The inverse association observed between air pollution 
exposure and miRNA expression was accompanied by a positive association between air 
pollution exposure and PTEN expression, as expected. During normal pregnancy, placental 
PTEN expression decreases with the development of the placenta and as pregnancy 
progresses.
59
 Maccani et al. have reported that downregulation of miR-21 through induction 
of PTEN in placenta could lead to reduced invasion of maternal decidua, migration and 
growth of placental cells.
37
 
Aberrant expression of immune-related target genes, such as TLR4, has been 
associated with inflammation-induced preterm delivery,
60
 and the activation of NF-B with 
increased oxidative stress resulting in pregnancy complications, e.g., preeclampsia.
61
 Low 
expression of angiogenesis-related genes (MMP2, VEGF, TGF-β) and high expression of 
apoptosis-related genes (caspases) have been associated with recurrent pregnancy loss.
62 
Placental vascular development is a crucial process for fetal development ensuring an optimal 
blood flow between fetus and mother, and an increased uterine vascular resistance and 
reduced blood flow have been associated with pregnancy complications and fetal growth 
retardation.
63
 
In addition, under normal conditions in early pregnancy, genes regulating cell cycle, 
differentiation, metabolic process, and angiogenesis are overexpressed, whereas genes 
involving in metabolic process, stress response, signaling and ion transport are upregulated in 
late pregnancy.
64
 However, in our study, we only measured the miRNA expression at birth; 
thereby, the regulation of miRNA targets across the different time windows of pregnancy 
cannot be assessed. 
A limitation of this study is that placental tissue is composed of a complex population 
of cells (syncytiotrophoblasts/cytotrophoblasts, mesenchymal cells, Hofbauer cells, and 
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fibroblasts). To minimize the impact of regional differences we combined 4 fetal samples 
taken at four standardized sites across the middle region of the placenta (approximately 4 cm 
away from the umbilical cord) to extract miRNAs. Regardless of this, the placenta might be 
used as a proxy for epigenetic changes in the fetus, as it is derived from the outer layer of the 
blastocyst. The organ has a great plasticity to a range of intrauterine conditions and 
exposures. We cannot answer whether epigenetic alterations in placental tissue affect the 
fetus in a direct manner or indirectly by adaptations in its function. Secondly, although our 
results were robust and independent of other studied factors, we cannot eliminate the 
possibility of residual confounding by some unknown factor that is associated with both 
miRNA expression and ambient air pollution. Season and apparent temperature were taken 
into account as epigenetic adaptive changes to season have been reported.
65
 Our study was 
not designed to evaluate temporal changes of miRNA expression during pregnancy and may 
be hampered by the fact that assays of term placentas may not reflect in vivo miRNA 
expression patterns occurring earlier at critical points of development. 
In conclusion, we observed significant associations between PM exposure and 
miRNA (miR-20a, miR-21, miR-146a, and miR-222) and mRNA (PTEN) expression. The 
second trimester was identified as the most significantly affected time window for the 
analyzed miRNAs. The potential regulation of immune-, cell cycle-, and angiogenesis-related 
pathways could underlie the observed miRNA expression changes due to early life exposure 
to particulate matter. 
Materials and Methods 
Study population 
The protocols of the ENVIRONAGE (ENVIRonmental influence ON AGEing) birth 
cohort are approved by the Ethics Committees of the University of Hasselt and the South-
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East-Limburg hospital (ZOL). Participating mothers provided written informed consent when 
they arrived at the hospital for delivery, and completed study questionnaires in the postnatal 
ward after delivery to provide detailed information on maternal age, pre-gestational BMI, 
maternal education, occupation, smoking status, alcohol consumption, place of residence, use 
of medication, parity, and newborn’s ethnicity. Past-smokers were defined as those who had 
quit smoking before pregnancy. Smokers continued smoking during pregnancy. Ethnicity was 
classified based on the native country of the newborn’s grandparents as European-Caucasian 
(when two or more grandparents were European) or non-European (when at least three 
grandparents were of non-European origin). We asked women whether they occasionally 
consumed alcohol during pregnancy. Maternal education was coded as low (no diploma or 
primary school), middle (high school), or high (college or university degree). 
Placental tissue was collected and deep-frozen within 10 minutes after delivery. Four 
biopsies at the fetal side of placental villous tissue, shielded by the chorio-amniotic 
membrane, were obtained, preserved in RNA later overnight at 4
o
C, and then stored at -20
o
C. 
The biopsies were taken at four standardized locations across the middle point of placenta, at 
approximately 4 cm distance from the umbilical cord. 
Our study population (n=210) within ENVIRONAGE cohort was recruited from 
September 2011 to January 2014. In 210 placentas, miR-16, miR-20a, miR-21, miR-34a, 
miR-146a, and miR-222, were measured. To validate the miRNAs putative regulatory role on 
placental PTEN, we performed a validation study. The transcript of the placental PTEN gene, 
which is regulated by miR-20a, miR-21, and miR-222, was measured in 181 (86.2%) of the 
newborns. To clarify the generalizability of the study, we have compared the characteristics 
of these 210 mother-newborn pairs with the data of the birth register of Flanders (Northern 
part of Belgium). This register comprises all births from Flanders (n=648,711) from 1999-
2009.
66
 The main characteristics including maternal age, maternal education, parity, ethnicity, 
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and birth weight are in line with the birth register of all births between 1999-2009 in the 
Northern part of Belgium and therefore our sample of mother-newborn pairs can be 
considered to be representative for the population in Flanders (Supplementary Table S1). 
Air pollution exposure 
Air pollution exposure was assessed as described previously.
67
 In brief, we 
interpolated the regional background level of PM2.5 for each mother’s residential address 
using a spatial temporal interpolation method (Kriging) that employs pollution data collected 
in the official fixed site monitoring network and land cover data retrieved from satellite 
images (Corine land cover data set) in combination with a dispersion model. The utilized 
dispersion model was described previously.
68, 69
 This model chain provides daily PM2.5 values 
using data from the Belgian telemetric air quality network, combined with information from 
point sources and line sources which are interpolated to a high resolution receptor grid. In the 
Flemish region of Belgium, more than 80% of the temporal and spatial variability (R
2
) could 
be explained by the interpolation tool.
70
 To explore potentially critical exposures during 
pregnancy, individual mean PM2.5 concentrations (µg/m
3
) were calculated for various periods, 
for which the date of conception was estimated based on ultrasound data: each of the three 
trimesters of pregnancy, with trimesters being defined as: 1-13 weeks (1
st
 trimester), 14-26 
weeks (2
nd
 trimester), and 27 weeks to delivery (3
rd
 trimester). Additionally, nitrogen dioxide 
(NO2) exposure was interpolated using the same methods as PM2.5 exposure. We have 
complete residential information during and before pregnancy. For those that moved during 
pregnancy (n=20, 9.5%), we calculated exposure windows accounting for the address 
changes during this period. 
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RNA isolation and DNase treatment 
Total RNA and miRNA were isolated from pooled biopsies using the miRNeasy mini 
kit (Qiagen, KJ Venlo, the Netherlands) according to the manufacturer’s protocol. Quality 
control of the extracted total RNA and miRNA was assessed by spectrophotometry 
(Nanodrop ND-1000; Isogen Life Science, De Meern, the Netherlands). Sample purity was 
assessed by calculating the A260/280 and A260/230 ratios. The average (±SD) yield of total RNA 
per placenta biopsy was 4.4 (±1.2) µg with average A260/280 ratio of 1.96 (±0.03) and average 
A260/230 ratio of 1.85 (±0.18). DNase treatment was performed on extracted RNA samples 
according to the manufacturer’s instructions (Turbo DNA-free kit, Ambion, Life 
Technologies, Diegem, Belgium). Extracted RNA was stored at -80 °C until further use. In a 
pilot experiment, the variability within the four individual biopsies was assessed in a subset 
of ten placental tissues. The average Cq values of miRNAs (miR-21, miR-222, and RNU6) 
within the four biopsies of each placenta varied between 2-9% (CV). To reduce interplacental 
differences, we used pooled samples from 4 placental biopsies. 
Reverse transcription and miRNA expression analysis 
RNA was reverse transcribed using the Megaplex reverse transcription (RT) stem-
loop primer pool A (Applied Biosystems, Foster City, CA), enabling miRNA specific cDNA 
synthesis of 380 different human miRNAs and small RNA controls, according to the 
manufacturer’s protocol. Briefly, 375 ng total RNA was reverse transcribed as follows: 2 
minutes at 16°C, 1 minute at 42°C and 1 minute at 50°C, for 40 cycles (Thermocycler PCR, 
Techne, Staffordshire, UK). Afterwards, cDNA was stored at -20°C for a maximum of one 
week until qRT-PCR measurements were performed. 
miRNA qRT-PCR analysis was performed using Taqman miRNA assays (Applied 
Biosystems, Foster City, CA), according to the manufacturer’s protocol. All target sequences 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ite
it H
as
se
lt]
, [
Ka
ren
 V
rije
ns]
 at
 07
:44
 25
 A
pri
l 2
01
6 
 18 
 
of the miRNAs and control RNA are available in Supplementary Table S2. An input of 5ng 
cDNA was used for PCR reactions, which were run on a 7900HT Fast Real-Time PCR 
System (Applied Biosystems, Foster City, CA), as follows: a polymerase activation for 2 
minutes at 50°C, a denaturation step for 10 min at 95°C and an anneal/extension step (40 
cycles) for 15 seconds at 95°C and for 1 min at 60°C. For normalization the endogenous 
control RNU6 was used. In order to minimize the technical variation between the different 
runs of the same miRNA assay, inter-run calibrators (IRCs) were applied. Expression of 
candidate miRNAs was studied and Cq values were collected with SDS 2.3 software. 
Amplification efficiencies were between 90-115% for all assays. The relative miRNA 
expression was calculated by 2
-ΔΔCq
 method using qBase plus software (Biogazelle, Belgium). 
Data is presented as relative quantities of target miRNA normalized to endogenous control 
miRNA. All samples were analyzed in triplicate. Replicates were included when the ΔCq was 
smaller than 0.5. 
miRNA target prediction and pathway analysis 
Many in silico prediction tools have been developed to identify putative miRNA-
target genes. We utilized miRTarBase
71
 and DIANA–TarBase72 for prediction of targets for 
those miRNAs that revealed significant associations with in utero air pollution exposure, 
namely miR-16, miR-20a, miR-21, miR-34a miR-146a, and miR-222. miRTarBase v6.0 
includes many miRNA-target interactions, retrieved manually from research articles in 
literature related to functional studies of human miRNAs.
71
 DIANA-TarBase v7.0 identifies 
miRNA-target interactions which have been highly curated from published experiments.
73
 
The available experimental evidence on prediction of miRNA targets was used as a 
determinant for the selection of target genes. We considered reporter assay (RS), qPCR (qP), 
Western blot (WB), and immunoprecipitation (IP) as strong evidenced assays, while assays 
included high-throughput analyses such as microarrays (MA), proteomics (Pr), and next 
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generation sequencing (NGS) were considered as less strongly evidenced. The identified 
putative miRNA targets were ranked based on available strong evidenced assays and, 
subsequently, the top 15 targets were selected for analysis. 
MetaCore™ (Thomson Reuters, New York, USA) was used for pathway analysis. We 
performed pathway analysis by overrepresentation analysis for each set (n=15) of predicted 
miRNAs target genes of miR-20a, miR-21, miR-146a, and miR-222. MiR-16 and miR-34a 
were excluded from pathway analysis, as we did not observe significant associations for these 
miRNAs with in utero air pollution exposure. The obtained P-values were corrected for 
multiple hypotheses testing by applying Benjamini and Hochberg’s FDR.74 Extended lists of 
enriched pathway maps (n=50) are provided in Supplementary Table S3. Additionally, we 
identified the shared pathways regulated by the miRNAs of interest. The list of common 
pathways (n=33) regulated by these miRNAs with their P-values and FDR is given in 
Supplementary Table S4. 
miRNA target validation by qRT-PCR 
The validation of a common miRNA target was performed in a subset (n=181, 
86.2%). Total RNA (3 μg) were reverse transcribed into cDNA by GoScript Reverse 
Transcription System (Promega, Madison, WI, USA) using Thermal cycler (TC-5000; 
Techne, Burlington, NJ, USA). The synthetized cDNA was stored at –20°C for further 
applications. 
qRT-PCR analysis was performed using a 7900HT Fast Real-Time PCR System 
(Applied Biosystems, Foster City, CA), according to the manufacturer’s protocol. PTEN, as 
target gene (primer assay: Hs.PT.58.4416071, RefSeq number: NM_000314), and GAPDH 
(primer assay: Hs.PT.53a.24391631.gs, RefSeq number: NM_001256799), IPO8 (primer 
assay: Hs.PT.56a.40532361, RefSeq number: NM_001190995), UBC (primer assay: 
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Hs.PT.39a.22214853, RefSeq number: NM_021009), and POLR2A (primer assay: 
Hs.PT.56a.25515089, RefSeq number: NM_000937), as reference genes were measured. An 
input of 6ng of cDNA was added to TaqMan Fast Advanced Master Mix (Life Technologies) 
and PrimeTimeTM assay (Integrated DNA Technologies, Coralville, IA, USA). The same 
cycling conditions as previously mentioned were used. Inter-run calibrators and reference 
genes were used for normalization. The expression of target and reference genes was 
measured, and the Cq values were collected using SDS 2.3 software. The raw data were 
processed to normalized relative gene expression by 2
-ΔΔCq
 method using qBase plus software 
(Biogazelle, Belgium). The amplification efficiencies for all assays were within the 
acceptable range (90-115%) (data not shown). All samples were analyzed in triplicate and 
replicates were included when the ΔCq was smaller than 0.5. 
Statistical analysis 
For database management and statistical analysis, we used SAS software (Version 9.3 
SAS Institute, Cary, NC, USA). We tested the normality of the obtained relative quantities of 
miRNA expression. Because of non-normal distribution the relative miRNA expressions 
were log-transformed. Categorical data are presented as frequencies (%) or numbers and 
continuous data as mean (±SD). We performed multiple linear regression to assess the 
independent associations between placental miRNA expression and in utero exposure to 
particulate air pollution, while adjusting for maternal age (years), pre-gestational body mass 
index (BMI) (kg/m
2
), smoking status (never-smoker, past-smoker, or current-smoker), 
educational status (low, middle or high), parity (1, 2, or ≥3), and newborn’s gender, 
gestational age (weeks) and ethnicity, seasonality (at conception) and apparent temperature 
during the 3
rd
 trimester of pregnancy divided into quartiles of the distribution. Using the same 
model, the association between relative miRNA expression and air pollution exposure was 
estimated for each trimesters of pregnancy. 
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Likewise, in a subsequent validation experiment, the relative placental PTEN 
expression was first log-transformed and then associated with air pollution using the same 
multiple regression model, as described in the previous paragraph. Pearson correlations 
between miRNAs of interest and PTEN expression were evaluated. 
The effect of air pollutants on miRNA/mRNA expression is presented as percentage 
of change [change (%) =(10 
(β*5)
 – 1)*100] with 95% confidence intervals (CI), for each 5-
µg/m
3
 increment in air pollution exposure at each time window. 
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Table 1. Characteristics of mother-newborn pairs. 
Characteristics  
Mean ± SD / 
Frequency (%) 
  
Original 
study 
(n=210)  
Validation 
study 
(n=181) 
Maternal     
Age, years 
29.5 ± 
4.3 
29.4 ± 4.2 
Pre-gestational 
BMI, kg/m
2
 
24.1 ± 
4.8 
24.3 ± 5.0 
   
Smoking status 
147 
(70.0) 
129 (71.3) 
   
Never-smoker 32 (15.2) 27 (14.9) 
   
Past-smoker 31 (14.8) 25 (13.8) 
Current- 
smoker 
106 
(50.5) 
89 (49.2) 
   
Parity 84 (40.0) 74 (40.9) 
1 20 (9.5) 18 (9.9) 
   
2 23 (10.9) 20 (11.1) 
≥3 69 (32.9) 59 (32.6) 
Education 
118 
(56.2) 
102 (56.3) 
Low 
115 
(54.8) 
102 (56.3) 
Middle 
39.2 ± 
1.3 
39.1 ± 1.3 
   
High 
3,395 ± 
427 
3,384 ± 
429 
Newborn 
190 
(90.5) 
163 (90.1) 
Gender 20 (9.5) 18 (9.9) 
Female 53 (25.2) 46 (25.4) 
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Gestational age, 
weeks 
52 (27.8) 45 (24.9) 
   
Birth weight, g 52 (27.8) 44 (24.3) 
   
Ethnicity 53 (25.2) 46 (25.4) 
European-
Caucasian 
57 (27.1) 53 (29.3) 
Non-European 50 (23.8) 38 (21.0) 
   
Other 61 (29.1) 55 (30.4) 
 
42 (20.0) 35 (19.3) 
Apparent 
Temperature, 
o
C 
    
   
Third trimester 
(quartiles) 
    
   
< Q1     
   
≥ Q1 and < Q2     
   
   
≥ Q2 and < Q3     
   
   
≥ Q3     
Seasonality (at 
conception) 
    
   
Winter     
   
Spring     
Summer     
Fall     
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Table 2. Characteristics of particulate air pollution exposure. Averaged for each mother-
newborn pair during the different time windows during pregnancy. 
Air 
pollutant 
(µg/m
3
) 
Mean 
± SD 
IQR 
10
th
 
Percentile 
90
th 
Percentile 
Original 
study 
(n=210) 
        
     
PM2.5 
15.99 
± 
5.29 
8.08 10.22 24.65 
Trimester 
1 (1-13 w) 
16.38 
± 
5.06 
8.19 10.39 23 
Trimester 
2 (14-26 
w) 
16.74 
± 
5.82 
9.43 10.07 25.54 
Trimester 
3 (27-
delivery) 
19.97 
± 
5.86 
9.09 12.74 28.06 
NO2 
20.69 
± 
6.04 
7.95 12.98 29.1 
     
Trimester 
1 (1-13 w) 
20.91 
± 
6.46 
8.49 12.74 29.35 
     
Trimester 
2 (14-26 
w) 
        
Trimester 
3 (27-
delivery) 
        
Validation 
study 
(n=181) 
        
     
PM2.5 
16.12 
± 
5.32 
8.13 10.28 24.87 
Trimester 
1 (1-13 w) 
16.49 
± 
5.07 
8.33 10.59 23.04 
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Trimester 
2 (14-26 
w) 
16.93 
± 
5.98 
10.07 10.08 25.77 
Trimester 
3 (27-
delivery) 
20.18 
± 
5.85 
9.23 12.79 28.09 
NO2 
20.85 
± 
6.24 
8.6 13.01 29.72 
Trimester  20.99 8.28 12.69 29.84 
1 (1-13 w) 
 ± 
6.64 
   
Trimester 
2 (14-26 
w) 
        
Trimester 
3 (27-
delivery) 
        
Validation 
study 
(n=181) 
        
     
PM2.5 
16.12 
± 
5.32 
8.13 10.28 24.87 
Trimester 
1 (1-13 w) 
16.49 
± 
5.07 
8.33 10.59 23.04 
     
Trimester 
2 (14-26 
w) 
16.93 
± 
5.98 
10.07 10.08 25.77 
Trimester 
3 (27-
delivery) 
20.18 
± 
5.85 
9.23 12.79 28.09 
NO2 
20.85 
± 
6.24 
8.6 13.01 29.72 
Trimester 
1 (1-13 w) 
20.99 
± 
6.64 
8.28 12.69 29.84 
     
Trimester 
2 (14-26 
w) 
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Trimester 
3 (27-
delivery) 
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Table 3. In silico putative mRNA targets for placental miRNAs under study. For each 
miRNA, the mRNA targets (n=15), description, function and the experimentally validated 
methods are indicated. 
miRNAs Target 
mRNAs 
Description Function Validated methods 
miR-16 CCNE1 
 
Cyclin E1 Cell cycle RS, WB, qP, NGS 
[b]
, 
MA 
[a,b]
, IP 
[a]
 
 BCL2 B-cell CLL/lymphoma 2 Apoptosis RS, WB, qP, MA, NGS 
[b]
, IP 
[a]
 
 ARL2 ADP-ribosylation factor-like 2 Cell cycle RS, WB, qP 
[b]
, MA 
[a,b]
, 
IP 
[a]
 
 HMGA1 High mobility group AT-hook 
1 
Controls many cellular 
processes 
RS, WB, qP, NGS 
[b]
, IP 
[a]
 
 CDK6 Cyclin-dependent kinase 6 Cell cycle RS, WB, qP, NGS 
[b]
, IP 
[a]
 
 CCND1 Cyclin D1 Cell cycle RS, WB, qP, NGS 
[b]
, IP 
[a]
 
 CCND3 Cyclin D3 Cell cycle RS, WB, qP 
[b]
, IP 
[a]
 
 CHUK Conserved Helix-Loop-Helix 
Ubiquitous Kinase 
NF-kappa-B signaling 
pathway 
RS 
[b]
, WB, qP 
[a,b]
, IP 
[a]
 
 RECK Reversion-Inducing-Cysteine- Suppressor of tumorigenicity RS, WB, qP, NGS 
[b]
, IP 
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Rich Protein With Kazal 
Motifs 
[a]
 
 CAPRIN1 Cell cycle associated protein 1 Synaptic plasticity in neurons 
& cell proliferation 
RS, WB, qP 
[b]
, IP 
[a]
 
 PPM1D Protein phosphatase, 
Mg
+2
/Mn
+2
dependent, 1D 
Cell cycle RS, WB, qP 
[b]
, IP 
[a]
 
 HMGA2 High Mobility Group AT-
Hook 2 
Cell cycle RS, WB, qP 
[b]
, IP 
[a]
 
 FGFR1 Fibroblast Growth Factor 
Receptor 1 
Controls many cellular 
processes 
RS, WB, qP 
[b]
, IP 
[a]
 
 ZYX Zyxin Signal transduction RS, WB, qP 
[b]
, IP 
[a]
 
 VEGFA Vascular endothelial growth 
factor A 
Angiogenesis & endothelial 
cell growth 
RS, WB, qP 
[a,b]
, NGS 
[b]
 
miR-20a TGFBR2 Transforming growth factor, 
beta receptor II 
Controls many cellular 
processes 
RS 
[a,b]
, WB, qP, 
MA,NGS 
[b]
, IP 
[a]
 
 E2F1 E2F transcription factor 1 Cell cycle & DNA 
replication 
RS, WB, qP, MA, NGS 
[b]
, IP 
[a]
 
 CDKN1A Cyclin-Dependent Kinase 
Inhibitor 1A 
Cell cycle RS, WB, qP 
[a,b]
, NGS 
[b]
, IP 
[a]
 
 STAT3 Signal Transducer And 
Activator Of Transcription 3 
(Acute-Phase Response 
JAK-STAT signaling 
cascade 
RS, WB, qP, MA, NGS 
[b]
, IP 
[a]
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Factor) 
 LIMK1 LIM Domain Kinase 1 Regulation of actin filament 
dynamics & signal 
transduction 
RS, WB, qP, MA 
[b]
, IP 
[a]
 
 DUSP2 Dual Specificity Phosphatase 2 Regulates mitogenic signal 
transduction 
RS, WB, qP, NGS 
[b]
, IP 
[a]
 
 BMPR2 Bone morphogenetic protein 
receptor, type II 
(serine/threonine kinase) 
Endochondral bone 
formation & embryogenesis 
RS, WB, qP, NGS 
[b]
, IP 
[a]
 
 APP Amyloid beta (A4) precursor 
protein 
Neurite growth, neuronal 
adhesion & axonogenesis 
RS, WB, qP 
[b]
, IP 
[a]
 
 RUNX1 Runt-related transcription 
factor 1 
Development of normal 
hematopoiesis 
RS, WB, qP 
[b]
, IP 
[a]
 
 MAP3K5 Mitogen-Activated Protein 
Kinase Kinase Kinase 5 
In cascades of cellular 
responses 
RS, WB, qP 
[b]
, IP 
[a]
 
 HIF1A Hypoxia Inducible Factor 1, 
Alpha Subunit 
Energy metabolism, 
angiogenesis, apoptosis 
RS, WB, qP, NGS 
[b]
 
 BNIP2 BCL2/adenovirus E1B 19kDa 
interacting protein 2 
Suppression of cell death WB, qP, NGS 
[b]
, IP 
[a]
 
 CCND1 Cyclin D1 Cell cycle RS 
[a,b]
, WB, qP, NGS 
[b]
 
 PTEN Phosphatase and tensin Tumor suppressor RS 
[a,b]
, WB, qP, NGS 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ite
it H
as
se
lt]
, [
Ka
ren
 V
rije
ns]
 at
 07
:44
 25
 A
pri
l 2
01
6 
 38 
 
homolog 
[b]
 
 KIT v-kit Hardy-Zuckerman 4 
feline sarcoma viral oncogene 
homolog 
Proto-oncogene RS, WB, qP, MA 
[b]
 
miR-21 BTG2 BTG family, member 2 Cell cycle RS, WB, qP, MA,NGS 
[b]
, IP 
[a]
 
 PDCD4 Programmed cell death 4 
(neoplastic transformation 
inhibitor) 
Inhibits translation initiation RS, WB, qP, MA,NGS 
[b]
, IP 
[a]
 
 TGFBR2 Transforming growth factor, 
beta receptor II 
Controls many cellular 
responses 
RS, WB, qP, MA 
[a,b]
, 
IP 
[a]
 
 NFIB Nuclear Factor I/B Transcription & replication RS, WB, qP 
[b]
, IP, MA 
[a]
 
 CDC25A Cell Division Cycle 25A Cell cycle RS, qP, NGS 
[b]
, MA 
[a,b]
, IP 
[a]
 
 RASGRP
1 
RAS guanyl releasing protein 
1 (calcium and DAG-
regulated) 
Regulates T- & B-cells 
development 
RS, WB, qP, NGS 
[b]
, 
MA 
[a,b]
 
 JAG1 Jagged 1 Notch signaling- in cell-fate 
during hematopoiesis, in 
early & late stages of 
mammalian cardiovascular 
development 
RS, WB, NGS 
[b]
, IP 
[a]
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 APAF1 Apoptotic peptidase activating 
factor 1 
Activation of CASP3 RS, WB, qP 
[b]
, MA 
[a,b]
 
 TIMP3 TIMP metallopeptidase 
inhibitor 3 
Inhibits matrix 
metalloproteinases 
RS, WB, qP, MA 
[a,b]
 
 SOX5 SRY (sex determining region 
Y)-box 5 
Transcription factor- 
embryonic development & 
cell fate 
RS, WB, qP, MA 
[b]
 
 RECK Reversion-inducing-cysteine-
rich protein with kazal motifs 
Tumor invasion and 
metastasis 
RS, WB, qP, MA 
[a,b]
 
 PTEN Phosphatase and tensin 
homolog 
Tumor suppressor RS, WB, qP, MA 
[a,b]
 
 TPM1 Tropomyosin 1 (alpha) Ca
+2
 dependent regulation of 
striated muscle contraction 
RS, WB, qP, MA 
[b]
 
 BCL2 B-cell CLL/lymphoma 2 Apoptosis RS, WB, qP, NGS 
[b]
 
 E2F1 E2F transcription factor 1 Cell cycle & DNA 
replication 
RS, WB, qP 
[b]
 
miR-34a  CDK6 Cyclin-dependent kinase 6 Cell cycle RS, WB, qP, MA 
[a,b]
, 
NGS 
[b]
, IP 
[a]
 
 CCNE2 Cyclin E2 Cell cycle RS, WB, qP, NGS 
[b]
, 
MA 
[a,b]
, IP 
[a]
 
 E2F3 E2F transcription factor 3 Cell cycle & DNA 
replication 
RS, NGS 
[b]
, WB, qP, 
MA 
[a,b]
, IP 
[a]
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 CDK4 Cyclin-dependent kinase 4 Cell cycle RS, WB, qP 
[a,b]
, MA 
[b]
, 
IP 
[a]
 
 NOTCH1 Notch 1 Variety of developmental 
processes by controlling cell 
fate decisions- development 
RS, WB, qP 
[a,b]
, MA 
[b]
, 
IP 
[a]
 
 NOTCH2 Notch 2 Variety of developmental 
processes by controlling cell 
fate decisions- development 
RS, WB, qP, MA 
[a,b]
, 
IP 
[a]
 
 MYC v-myc avian myelocytomatosis 
viral oncogene homolog 
Cell cycle, apoptosis & 
cellular transformation 
RS, WB, qP, MA, NGS 
[b]
 
 JAG1 Jagged 1 Notch signaling- in cell-fate 
during hematopoiesis, in 
early & late stages of 
mammalian cardiovascular 
development 
RS, WB, qP 
[a,b]
, MA 
[b]
 
 CCND1 Cyclin D1 Cell cycle RS, NGS 
[b]
, WB, qP 
[a,b]
, 
 BCL2 B-cell CLL/lymphoma 2 Apoptosis RS, WB, qP 
[a,b]
, MA 
[b]
 
 MYB V-Myb Avian Myeloblastosis 
Viral Oncogene Homolog 
Hematopoiesis & 
tumorigenesis 
RS, MA 
[a,b]
, WB, qP 
[b]
 
 SIRT1 Sirtuin 1 Coordination of several 
separated cellular functions 
such as cell cycle, 
RS, WB, qP 
[a,b]
, MA 
[a]
 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ite
it H
as
se
lt]
, [
Ka
ren
 V
rije
ns]
 at
 07
:44
 25
 A
pri
l 2
01
6 
 41 
 
 HNF4A Hepatocyte nuclear factor 4, 
alpha 
Development of RS, WB, MA 
[a,b]
, qP 
[b]
 
 MET MET Proto-Oncogene, 
Receptor Tyrosine Kinase 
Controls many cellular 
processes 
RS 
[b]
, WB, qP, MA 
[a,b]
 
 MYCN V-Myc Avian 
Myelocytomatosis Viral 
Oncogene Neuroblastoma 
Derived Homolog 
Transcription factor RS, WB, qP, MA 
[b]
 
miR-146a IRAK1 Interleukin-1 Receptor-
Associated Kinase 1 
Innate immune response RS, qP, MA 
[b]
, WB 
[a,b]
, 
IP 
[a]
 
 PTGS2 Prostaglandin-Endoperoxide 
Synthase 2 (Prostaglandin G/H 
Synthase And 
Cyclooxygenase) 
Inflammatory prostaglandins RS, WB, qP 
[b]
, IP 
[a]
 
 
 STAT1 Signal Transducer And 
Activator Of Transcription 1, 
91kDa 
Mediates cellular responses 
to interferons & cytokines 
RS, WB, qP 
[b]
, IP 
[a]
 
 
 NFKB1 Nuclear factor of kappa light 
polypeptide gene enhancer in 
B-cells 1 
Transcription factor-immune 
response 
RS, WB, qP, MA, NGS 
[b]
 
 CXCR4 Chemokine receptor 4 Maintenance of immune 
function 
RS, qP, MA 
[b]
, WB 
[a,b]
 
 SMAD4 SMAD family member 4 TGF-beta signaling RS, WB, qP 
[a,b]
, MA 
[b]
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 BRCA1 Breast cancer 1, early onset Tumor suppressor & 
maintains genomic stability 
RS, WB, qP, MA 
[b]
 
 EGFR Epidermal growth factor 
receptor 
Controls many cellular 
responses 
RS, qP 
[b]
, WB 
[a,b]
 
 TLR2 Toll-Like Receptor 2 Innate immune system RS,WB 
[b]
, qP 
[a,b]
 
 TRAF6 TNF receptor-associated factor 
6, E3 ubiquitin protein ligase 
Immune response RS, WB, qP, MA 
[b]
 
 TLR4 Toll-like receptor 4 Innate immune system RS, WB, qP, MA 
[b]
 
 CD40LG CD40 Ligand Immune system RS, WB, qP 
[b]
 
 CARD10 Caspase Recruitment Domain 
Family, Member 10 
Apoptosis RS, WB, qP 
[a,b]
 
 NUMB Numb Homolog (Drosophila) Cell fates during 
development & neurogenesis 
RS, WB, qP 
[b]
 
 ELAVL1 ELAV Like RNA Binding 
Protein 1 
Variety of biological 
processes & diseases 
RS, WB, qP 
[b]
 
miR-222 CDKN1B Cyclin-Dependent Kinase 
Inhibitor 1B 
Cell cycle RS, WB 
[a,b]
, qP, MA, 
NGS 
[b]
, IP 
[a]
 
 FOS FBJ murine osteosarcoma viral 
oncogene homolog 
Signal transduction, cell 
proliferation & 
differentiation 
RS, WB, qP, NGS 
[b]
, IP 
[a]
 
 TRPS1 Trichorhinophalangeal Transcriptional repressor RS, WB, qP, MA 
[b]
, IP 
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syndrome I 
[a]
 
 ETS1 V-Ets Avian Erythroblastosis 
Virus E26 Oncogene Homolog 
1 
Transcription factor in wide 
variety of different cellular 
processes 
RS 
[a,b]
, WB, qP 
[b]
, IP 
[a]
 
 
 KIT v-kit Hardy-Zuckerman 4 
feline sarcoma viral oncogene 
homolog 
Proto-oncogene RS 
[a,b]
, WB, qP, MA 
[b]
 
 SOD2 Superoxide Dismutase 2, 
mitochondrial 
Binds to O2
-
 RS, WB, qP, MA 
[b]
 
 MMP1 Matrix metallopeptidase 1 Cleaves collagens RS, WB, qP, MA 
[b]
 
 PTEN Phosphatase and tensin 
homolog 
Tumor suppressor RS, WB, qP, MA 
[b]
 
 STAT5A Signal transducer and activator 
of transcription 5A 
Signal transduction & 
activation of transcription 
RS, WB, qP 
[b]
 
 FOXO3 Forkhead box O3 Transcription factor for 
apoptosis 
RS, WB, qP 
[b]
 
 CDKN1C Cyclin-dependent kinase 
inhibitor 1C 
Negative regulator of cell 
proliferation 
RS 
[a,b]
, WB, qP 
[b]
 
 ESR1 Estrogen receptor 1 Controls many cellular 
processes 
RS, WB, qP 
[b]
 
 TMED7 Transmembrane Emp24 
Protein Transport Domain 
Vesicular protein trafficking WB, qP 
[b]
, IP 
[a]
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Containing 7 
 CERS2 Ceramide Synthase 2 Regulates cell growth RS, WB, qP 
[b]
 
 
 DKK2 Dickkopf WNT Signaling 
Pathway Inhibitor 2 
In embryonic development & 
Wnt signaling 
RS, WB, qP 
[b]
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Table 4. Functional enrichment analysis for the putative target genes of deregulated miRNAs 
in association with air pollution exposure (miR-20a, miR-21, miR-146a, and miR-222). The 
top 5 enriched MetaCore
TM
 pathways, the P-value, FDR (P-value corrected for multiple 
testing) and the genes present in our dataset and involved in the listed pathways are provided.  
Pathways 
P-
valu
e 
%F
DR 
Genes involved 
miR-20a targets    
Upregulation of MITF in melanoma 7.24
E-07 
1.00
E-04 
E2F1, c-Kit, CDKN1A (p21), HIF1A 
Cell cycle: Regulation of G1/S transition 
(part 1) 
9.05
E-07 
1.00
E-04 
Cyclin D1, CDKN1A (p21), Cyclin D, 
TGF-beta receptor type II 
Transcription Androgen Receptor nuclear 
signaling 
1.81
E-06 
1.34
E-04 
Cyclin D1, CDKN1A (p21), TGF-beta 
receptor type II, STAT3 
IL-6 signaling in multiple myeloma 3.01
E-06 
1.56
E-04 
Cyclin D1, E2F1, CDKN1A (p21), 
STAT3 
Cell cycle: Influence of Ras and Rho 
proteins on G1/S Transition 
3.52
E-06 
1.56
E-04 
Cyclin D1, E2F1, CDKN1A (p21), 
STAT3 
miR-21 targets    
Development: Regulation of epithelial-to-
mesenchymal transition (EMT) 
9.98
E-07 
1.45
E-04 
Jagged1, TGF-beta receptor type II, 
Tropomyosin-1, Bcl-2 
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Apoptosis and survival: p53-dependent 
apoptosis 
6.02
E-06 
4.36
E-04 
E2F1, Apaf-1, Bcl-2 
Cell cycle: 3.21
E-04 
9.37
E-03 
CDC25A, E2F1 
Mitogenic action of Estradiol / ESR1 
(nuclear) in breast cancer 
5.75
E-04 
9.37
E-03 
CDC25A, E2F1 
Cell cycle: Role of SCF complex in cell 
cycle regulation 
6.17
E-04 
9.37
E-03 
CDC25A, E2F1 
miR-146a targets    
Signal transduction: NF-kB activation 
pathways 
4.91
E-12 
1.32
E-09 
TLR2, TRAF6, NF-kB, NF-kB1 (p105), 
NF-kB1 (p50), IRAK1, TLR4 
Immune response: TLR2 and TLR4 
signaling pathways 
1.11
E-11 
1.50
E-09 
TLR2, TRAF6, NF-kB, NF-kB1 (p105), 
IRAK1, COX-2 (PTGS2), TLR4 
Immune response: Bacterial infections in 
normal airways 
4.20
E-10 
3.76
E-08 
STAT1, TLR2, TRAF6, NF-kB, IRAK1/2, 
TLR4 
Immune response: HSP60 and HSP70/ 
TLR signaling pathway 
7.71
E-10 
5.18
E-08 
TLR2, TRAF6, NF-kB, NF-kB1 (p105), 
IRAK1/2, TLR4 
Immune response: Role of PKR in stress-
induced antiviral cell response 
8.17
E-08 
4.40
E-06 
STAT1, TLR2, TRAF6, NF-kB, TLR4 
miR-222 targets    
Development: c-Kit ligand signaling 2.96 6.13 FOXO3A, c-Kit, CDKN1B (p27KIP1), 
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pathway during hemopoiesis E-06 E-04 STAT5 
Immune response: MIF-mediated 
glucocorticoid regulation 
6.45
E-06 
6.68
E-04 
ETS1, c-Fos, MMP-1 
Cell cycle: ESR1 regulation of G1/S 
transition 
2.26
E-05 
1.20
E-03 
CDKN1B (p27KIP1), c-Fos, ESR1 
(nuclear) 
Immune response: Oncostatin M signaling 
via MAPK in human cells 
3.20
E-05 
1.20
E-03 
c-Fos, MMP-13, MMP-1 
Immune response: IL-7 signaling in T 
lymphocytes 
3.47
E-05 
1.20
E-03 
FOXO3A, STAT5A, STAT5 
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Figure 1. Associations of relative miRNA expression with in utero exposure to air 
pollution. Associations are presented as percentage changes in relative miRNA (miR-16, 
miR-20a, miR-21, miR-34a, miR-146a, and miR-222) expression across the three trimesters 
of pregnancy, for each 5 µg/m
3
 increase in PM2.5 exposure (black square) and in NO2 
exposure (grey triangle). Estimates were adjusted for newborn’s gender, gestational age 
(weeks) and ethnicity (European, non-European), maternal age (years), pre-gestational BMI 
(kg/m
2
), smoking status (never-, past- or current-smoker), educational status (low, middle or 
high), parity (1, 2, or ≥3), seasonality at conception and apparent temperature (during the 
third trimester). Asterisk (*) indicates statistically significant (P<0.05). 
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Figure 2. Common putative pathways regulated by identified targets of the significant 
miRNAs. The top 10 shared pathways for targets of miR-20a, miR-21, miR-146a, and miR-
222 are ranked based on their minimum P-value, provided by MetaCore
TM
. Pathways 
regulated by miR-20a are indicated with orange bars, miR-21 with blue bars, miR-146a with 
red bars, and miR-222 with green bars. Size of the bars is indicative of the P-value for that 
respective miRNA. 
  
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ite
it H
as
se
lt]
, [
Ka
ren
 V
rije
ns]
 at
 07
:44
 25
 A
pri
l 2
01
6 
 50 
 
 
Figure 3. Gene network among the putative miRNA targets. A gene network 
(MetaCore
TM
) was generated for the potential connections of at least two miRNA-targets. 
The orange rounded rectangle corresponds to miR-20a, blue to miR-21, red to miR-146a, and 
green to miR-222 targets. The green arrows show activation, the red arrows indicate 
inhibition, and the grey arrows are unspecified connections. 
Details for the genes shown in the figure: AML1 (RUNX1): Runt-related transcription factor 
1; APP: Amyloid beta (A4) precursor protein; ASK1 (MAP3K5): Mitogen-Activated Protein 
Kinase Kinase Kinase 5; BTG2: BTG family, member 2; CCND: Cyclin D; CDC25: Cell 
Division Cycle 25; CDKN1A (p21): Cyclin-Dependent Kinase Inhibitor 1A; CDKN1B 
(p21KIP1): Cyclin-dependent kinase inhibitor 1A/B; ELAVL1: ELAV Like RNA Binding 
Protein 1; ESR: Estrogen receptor; FOXO3A Forkhead box O 3A; GPCRs (CXCR4): 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ite
it H
as
se
lt]
, [
Ka
ren
 V
rije
ns]
 at
 07
:44
 25
 A
pri
l 2
01
6 
 51 
 
Chemokine receptor 4 (G Protein-Coupled Receptors); IRAK1/2: Interleukin-1 Receptor-
Associated Kinase 1/2; c-KIT: v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene 
homolog; NFKB: Nuclear factor of kappa light polypeptide gene enhancer in B-cells; PTEN: 
Phosphatase and tensin homolog; SMAD4: SMAD family member 4; STAT1/5: Signal 
Transducer And Activator Of Transcription 1/5; TGFBR2: Transforming growth factor, beta 
receptor II; TPM1: Tropomyosin; TRAF6: TNF receptor-associated factor 6.  
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